Oxford Brain Diagnostics Ltd
Terry Pollard is currently the Chief Operating Officer at Oxford Brain Diagnostics Ltd, a company focused on bringing technology for the early and accurate detection of Alzheimer’s Disease to market. Previously, Terry has held roles as a Director at Global IP Consulting Ltd, an Associate at Kiatt, and worked in various business development and project management roles at companies such as Oxford University Innovation and Detica Ltd. Terry has a strong educational background, holding an MBA from Imperial College London and a MSci in Physics from the University of Bristol.
Oxford Brain Diagnostics Ltd
Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford Brain Diagnostics is committed to assessing brain health based on changes in the cellular structure, supporting drug development, and helping clinicians around the world in their fight to defeat Alzheimer’s and other neurodegenerative diseases.